These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 25125975

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
    Zou Y, Chen X, Liu J, Zhou DB, Kuang X, Xiao J, Yu Q, Lu X, Li W, Xie B, Chen Q.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
    [Abstract] [Full Text] [Related]

  • 4. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
    Wu Y, Shen Y, Zhang J, Wan C, Wang T, Xu D, Yang T, Wen F.
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
    [Abstract] [Full Text] [Related]

  • 5. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
    de Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez-Moragon E, Soriano JB, Viña AL, Bobolea I.
    Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF.
    Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
    [Abstract] [Full Text] [Related]

  • 7. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
    Li X, Wang T, Yang T, Shen Y, An J, Liu L, Dong J, Guo L, Li D, Zhang X, Chen L, Xu D, Wen F.
    Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
    [Abstract] [Full Text] [Related]

  • 8. Eosinophil and T cell markers predict functional decline in COPD patients.
    D'Armiento JM, Scharf SM, Roth MD, Connett JE, Ghio A, Sternberg D, Goldin JG, Louis TA, Mao JT, O'Connor GT, Ramsdell JW, Ries AL, Schluger NW, Sciurba FC, Skeans MA, Voelker H, Walter RE, Wendt CH, Weinmann GG, Wise RA, Foronjy RF.
    Respir Res; 2009 Nov 19; 10(1):113. PubMed ID: 19925666
    [Abstract] [Full Text] [Related]

  • 9. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
    Zhang M, Tang J, Yin J, Wang X, Feng X, Yang X, Shan H, Zhang Q, Zhang J, Li Y.
    Int J Chron Obstruct Pulmon Dis; 2018 Nov 19; 13():357-363. PubMed ID: 29403273
    [Abstract] [Full Text] [Related]

  • 10. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E, Bjermer L, Ekberg M.
    Int J Chron Obstruct Pulmon Dis; 2015 Nov 19; 10():881-9. PubMed ID: 26005341
    [Abstract] [Full Text] [Related]

  • 11. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, Feng M, Wen F.
    Int J Chron Obstruct Pulmon Dis; 2020 Nov 19; 15():397-407. PubMed ID: 32158205
    [Abstract] [Full Text] [Related]

  • 12. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
    Ishikawa N, Hattori N, Kohno N, Kobayashi A, Hayamizu T, Johnson M.
    Int J Chron Obstruct Pulmon Dis; 2015 Nov 19; 10():185-92. PubMed ID: 25670894
    [Abstract] [Full Text] [Related]

  • 13. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
    Golpe R, Martín-Robles I, Sanjuán-López P, Pérez-de-Llano L, González-Juanatey C, López-Campos JL, Arellano-Orden E.
    Int J Chron Obstruct Pulmon Dis; 2017 Nov 19; 12():2639-2646. PubMed ID: 28979110
    [Abstract] [Full Text] [Related]

  • 14. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
    Zeng YY, Hu WP, Zuo YH, Wang XR, Zhang J.
    Int J Chron Obstruct Pulmon Dis; 2019 Nov 19; 14():163-168. PubMed ID: 30655663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease.
    Attaran D, Lari SM, Towhidi M, Marallu HG, Ayatollahi H, Khajehdaluee M, Ghanei M, Basiri R.
    Int J Chron Obstruct Pulmon Dis; 2010 Oct 05; 5():335-40. PubMed ID: 21037957
    [Abstract] [Full Text] [Related]

  • 18. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
    Li D, Wu Y, Guo S, Qin J, Feng M, An Y, Zhang J, Li Y, Xiong S, Zhou H, Zeng Q, Chen L, Wen F.
    Int J Chron Obstruct Pulmon Dis; 2019 Oct 05; 14():1933-1941. PubMed ID: 31695352
    [Abstract] [Full Text] [Related]

  • 19. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S, Brüske I, Smith MP, Thorand B, Huth C, Ladwig KH, Kronenberg F, Heinrich J, Holle R, Peters A, Schulz H.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct 05; 11():1881-94. PubMed ID: 27574413
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.